Joseph Chi-lun Lo

Joseph joined Brunswick in London at the beginning of 2001 and relocated in 2004 to help set up the firm’s first Asia office in Hong Kong. Joseph has extensive experience driving significant corporate project work, including high profile IPOs, M&A and crisis situations across the region. In recent years, Joseph has led much of the firm’s work for Japanese clients.

During his time building Brunswick’s business in Asia, Joseph’s strong background in retail has been invaluable in his advisory role to luxury and sports & lifestyle retail group Kering, as they grow further in the China market; leading Japanese sportswear company ASICS, in their response to fatalities in their Cambodian factories; and the IPO of Chow Tai Fook, the world’s biggest pure play jewellery company.

As a former pharmacist, Joseph has also provided specialist insights and advice for his clients in this sector, including the agreed merger of Daiichi and Sankyo to form Japan's second largest pharmaceutical company, and the acquisition of OSI pharmaceuticals by Astellas, which was the first time a Japanese pharmaceutical company acquired a US listed business.

Beyond retail and pharmaceuticals, Joseph has led on financial market advisory work across a wider range of sectors, including financial services (private equity, banking and insurance), mining, chemicals, TMT and gaming. Other IPOs in Hong Kong include Samsonite, Prudential and HKT. HKT was a spin-off from PCCW and listed as share-stapled securities, which at the time, was unique to the Hong Kong market.

Joseph joined Brunswick from Boots the Chemists where for five years he managed a number of London pharmacies. He graduated with Honours from the London School of Pharmacy in 1995 with a Bachelor of Pharmacy. Joseph speaks native English and fluent Cantonese.